296 related articles for article (PubMed ID: 29630973)
1. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
3.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
5. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
7. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
Gore A; Horwitz V; Cohen M; Gutman H; Cohen L; Gez R; Kadar T; Dachir S
Exp Eye Res; 2018 Jun; 171():183-191. PubMed ID: 29548928
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo.
Zahir-Jouzdani F; Khonsari F; Soleimani M; Mahbod M; Arefian E; Heydari M; Shahhosseini S; Dinarvand R; Atyabi F
J Cell Physiol; 2019 Apr; 234(4):4702-4712. PubMed ID: 30191977
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RAP1 enhances corneal recovery following alkali injury.
Poon MW; Yan L; Jiang D; Qin P; Tse HF; Wong IY; Wong DS; Tergaonkar V; Lian Q
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):711-21. PubMed ID: 25574050
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn.
Doganay S; Firat PG; Cankaya C; Kirimlioglu H
Burns; 2013 Mar; 39(2):326-30. PubMed ID: 22922008
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor.
Chen L; Zhong J; Li S; Li W; Wang B; Deng Y; Yuan J
Drug Des Devel Ther; 2018; 12():2959-2969. PubMed ID: 30254425
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.
Li X; Zhou Q; Hanus J; Anderson C; Zhang H; Dellinger M; Brekken R; Wang S
Mol Pharm; 2013 Jan; 10(1):307-18. PubMed ID: 23186311
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
Wang Y; Yin H; Chen P; Xie L; Wang Y
Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model.
Kubota M; Shimmura S; Kubota S; Miyashita H; Kato N; Noda K; Ozawa Y; Usui T; Ishida S; Umezawa K; Kurihara T; Tsubota K
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):427-33. PubMed ID: 20847117
[TBL] [Abstract][Full Text] [Related]
16. Canonical NF-κB signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid.
Yu Q; Biswas S; Ma G; Zhao P; Li B; Li J
Elife; 2021 Jun; 10():. PubMed ID: 34085926
[TBL] [Abstract][Full Text] [Related]
17. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
18. Protective roles of the TIR/BB-loop mimetic AS-1 in alkali-induced corneal neovascularization by inhibiting ERK phosphorylation.
Liu Y; Shu Y; Yin L; Xie T; Zou J; Zhan P; Wang Y; Wei T; Zhu L; Yang X; Wang W; Cai J; Li Y; Yao Y; Wang X
Exp Eye Res; 2021 Jun; 207():108568. PubMed ID: 33839112
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization.
Jiang A; Li C; Gao Y; Zhang M; Hu J; Kuang W; Hao S; Yang W; Xu C; Gao G; Wang Z; Liu Z
Cornea; 2006 Dec; 25(10 Suppl 1):S36-40. PubMed ID: 17001191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
